Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma (Q24628879)

24 June 2017

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma (English)

1 reference

24 June 2017

0 references

8

0 references

Marc de Perrot

Marc de Perrot

14

0 references

Luis Chiriboga

Luis Chiriboga

5

0 references

Geoffrey Liu

Geoffrey Liu

13

0 references

Jonathan Melamed

Jonathan Melamed

4

0 references

Ming-Sound Tsao

Ming-Sound Tsao

15

0 references

Harvey I Pass

Harvey I Pass

1

0 references

author name string

Stephen M Levin

2

1 reference

24 June 2017

Michael R Harbut

3

1 reference

24 June 2017

Jessica Donington

6

1 reference

24 June 2017

Margaret Huflejt

7

1 reference

24 June 2017

David Chia

9

1 reference

24 June 2017

Lee Goodglick

10

1 reference

24 June 2017

Gary E Goodman

11

1 reference

24 June 2017

Mark D Thornquist

12

1 reference

24 June 2017

Chandra Goparaju

16

1 reference

24 June 2017

Michele Carbone

8

1 reference

24 June 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

The New England Journal of Medicine

24 June 2017

1 reference

24 June 2017

367

1 reference

24 June 2017

1417-1427

1 reference

24 June 2017

15

1 reference

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis

24 June 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

The meaning and use of the area under a receiver operating characteristic (ROC) curve

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Current status of screening for malignant pleural mesothelioma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Focus on molecules: fibulin-3 (EFEMP1).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Differential expression of fibulin family proteins in the para-cervical weak zone and other areas of human fetal membranes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Human fibulin-1D: molecular cloning, expression and similarity with S1-5 protein, a new member of the fibulin gene family

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Basic principles of ROC analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Use of death certificates in epidemiological studies, including occupational hazards: variations in discordance of different asbestos-associated diseases on best evidence ascertainment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Fibulins 3 and 5 antagonize tumor angiogenesis in vivo.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Gene expression profiles predict survival and progression of pleural mesothelioma.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3761217

Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases

28 November 2018

1 reference

12 December 2020

The CARET asbestos-exposed cohort: Baseline characteristics and comparison to other asbestos-exposed cohorts

1 reference

12 December 2020

Asbestos exposure, pleural mesothelioma, and serum osteopontin levels

1 reference

12 December 2020

Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins

1 reference

12 December 2020

Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity

1 reference

12 December 2020

Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1115050

1 reference

release_uhnrcndmi5e2tecbuvnbepgqfe

24 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uhnrcndmi5e2tecbuvnbepgqfe

24 November 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

3856106

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference